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Widespread Failure of Hematolymphoid
Differentiation Caused by a Recessive Niche-
Filling Allele of the Ikaros Transcription Factor
primarily concentrated on generating alleles that no
longer produce a protein. Relative to invertebrate ge-
nomes, the mammalian genome has undergone exten-
sive gene duplication and divergence (International Hu-
man Genome Sequencing Consortium, 2001; Venter et
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al., 2001) so that mutated genes often have closely re-Genetics Laboratory and
lated family members encoding proteins with the poten-Medical Genome Centre
tial to assume some of the functions of a missing protein.John Curtin School of Medical Research
This type of substitution masks the full functional spec-Australian National University
trum and specificity of genes that regulate the hemato-Canberra, ACT 2601
lymphoid system. The types of alleles that might bestAustralia
reveal mammalian gene function have received surpris-2 Department of Physiology
ingly little attention.Monash University
The transcription factor Ikaros is recognized as a keyClayton, VIC 3168
regulator of lymphocyte differentiation and is an exam-Australia
ple of a protein for which several different targeted al-3 Howard Hughes Medical Institute and
leles exist in mice. First identified as binding the pro-Department of Microbiology, Immunology
moter and enhancer regions of the lymphocyte-specificand Molecular Genetics
terminal deoxynucleotidyltransferase (TdT) (Lo et al.,University of California, Los Angeles
1991; Ernst et al., 1993) and TCR-CD3 genes (Georgo-Los Angeles, California 90095
poulos et al., 1992), respectively, primary Ikaros tran-4 Phenomix Corporation
scripts undergo alternate pre-mRNA splicing to gener-LPO Box A312
ate several protein isoforms (Hahm et al., 1994; Molna´rActon, ACT 2601
and Georgopoulos, 1994). The six zinc finger modulesAustralia
comply with the Kru¨ppel Cys2His2 consensus motif and
are arranged in two functionally distinct domains: four
N-terminal finger motifs dictate sequence specificitySummary
and DNA affinity, whereas two C-terminal fingers engage
these proteins in stoichiometric homo- and hetero-A central issue in understanding the hematolymphoid
dimeric complexes (Sun et al., 1996). Utilizing this struc-system is the generation of appropriate mutant alleles
tural difference, Ikaros’ biological function was originallyin mice to reveal the function of regulatory genes.
elucidated by two distinct targeted mutations in theHere we describe a mouse strain, Plastic, with a point
mouse germline. An internal deletion of the N-terminalmutation in a zinc finger of Ikaros that disrupts DNA
DNA binding zinc fingers (exons 3 and 4) forces overex-binding but preserves efficient assembly of the full-
pression of short dominant-negative isoforms (IkarosDN)length protein into higher order complexes. IkarosPlastic
that are normally rare and causes homozygous mutanthomozygosity is embryonically lethal with severe de-
mice to lack lymphocytes (Georgopoulos et al., 1994),fects in terminal erythrocyte and granulocyte differen-
while heterozygotes develop T cell neoplasia (Winandytiation, excessive macrophage formation, and blocked
et al., 1995). Homozygotes for a C-terminal mutationlymphopoiesis, while heterozygotes display a partial
(exon 7) that eliminates all protein (Ikarosnull) lack B andblock in lymphocyte differentiation. The contrast with
natural killer (NK) cells but develop T cells postnatally
more circumscribed effects of Ikaros alleles that ab-
(Wang et al., 1996). More recently, a hypomorphic strain
late the full-length protein highlights the importance in containing low amounts of Ikaros protein (IkarosL) gener-
mammals of generating recessive niche-filling alleles ated through an internal deletion (exon 2) that retains
that inactivate function without creating a void in multi- the DNA binding and dimerization domains produced a
molecular assemblies. milder lymphoid phenotype, with B cells in homozygotes
developing postnatally from a reduced precursor pool
Introduction (Kirstetter et al., 2002).
Ikaros’ molecular function appears to be dual: a tran-
Genetic analysis in mice represents a key tool for under- scriptional activator (Georgopoulos et al., 1992; Molna´r
standing the control of cell differentiation in the blood and Georgopoulos, 1994; Sun et al., 1996; Nichogianno-
and immune system. For genes such as c-kit and stem poulou et al., 1999) or potentiator that enhances the
cell factor, availability of an extensive series of allelic activity of weak and strong activators (Koipally et al.,
variants has helped illuminate the wide role of this recep- 2002), and a repressor. In evidence of the latter, Ikaros
tor-ligand system in blood cells (MGD, 2002). Production colocalizes to foci of pericentromeric heterochromatin
of mutant alleles by gene targeting in mouse embryonic with several transcriptionally inactive genes (Brown et
stem cells has greatly accelerated genetic dissection al., 1997, 1999) and associates with components of the
of the hematolymphoid system, but this approach has nucleosome remodeling and deacetylation (NURD)
complex that is active in chromatin remodeling and his-
tone deacetylation (Kim et al., 1999; reviewed in Georgo-*Correspondence: chris.goodnow@anu.edu.au
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poulos, 2002). Since Ikaros binds directly to major satel- Ikaros allele and the milder deletion mutations highlights
the issue of functional substitution among related geneslite DNA (Cobb et al., 2000) and mutations that disrupt
binding fail to downregulate target genes (Trinh et al., in the mammalian genome and the role of point mutant
alleles in revealing specific functions.2001; Sabbattini et al., 2001), it is an attractive candidate
for mediating the conversion of genes from active to
permanently inactive states (Smale and Fisher, 2002). Results
Given the phenotypes exhibited by mice lacking full-
length Ikaros protein and the associated biochemical Dominant T Cell Leukemia/Lymphoma
in an ENU-Induced Mutant Strainstudies, Ikaros is generally viewed as a key regulator
for lymphopoiesis, but its role in differentiation of other In a library bred from ENU-treated C57BL/6J (B6) mice, a
first generation (G1) male offspring developed leukemia/blood cell lineages is unclear. The possibility of a broader
role is raised by the presence of Ikaros mRNA at the lymphoma at 4 months of age, and a mutant breeding
line, Plastic (Plstc), was established by backcrossingearliest sites of hematopoiesis during ontogeny (Geor-
gopoulos et al., 1992) and in most differentiating lin- this founder to untreated B6 mice (Figure 1A). Lym-
phoma susceptibility was inherited as a single dominanteages (Morgan et al., 1997; Kelley et al., 1998; Klug et
al., 1998), and association between Ikaros and NURD in trait with 65% penetrance at an average age of 120
days in 742 descendents of the founder, spanning 12an erythroleukemic cell line (O’Neill et al., 2000). Variable
abnormalities in erythroid and myeloid cell numbers generations (Figure 1B). By flow cytometric analysis, the
predominant accumulating malignant cell type expressedhave been found in adult Ikarosnull and IkarosDN homozy-
gotes (Georgopoulos et al., 1994; Wang et al., 1996; the CD3-TCR complex (Figure 1C) and was highly
positive for the T cell marker Thy1, but negative for theNichogiannopoulou et al., 1999; Lopez et al., 2002) and
IkarosL/L adults and embryos (Dumortier et al., 2003), B cell markers B220, CD21, and  light chain, and did
not express markers for activated lymphocytes (CD69),along with subtle changes in embryonic/adult globin
ratios and erythrocyte/macrophage gene expression  T cells (TCR), progenitor cells (c-kit), macrophages
(Mac-1), granulocytes (Gr-1), or NK T cells (NK1.1) (data(Lopez et al., 2002). However, it is unclear whether these
relatively subtle abnormalities in other blood cells of not shown). Individual lymphoma cases varied in appar-
ent stage of T cell maturity based on expression ofadult mice are secondary to opportunistic infections, or
secondary to deficiencies in hematopoietic stem cells CD4, CD8, CD44, and CD25, with CD442548 and
CD442548 stages of differentiation arising with thein Ikarosnull and IkarosDN mice as measured by transfer/
reconstitution experiments (Nichogiannopoulou et al., highest frequency (27 of 83 animals) (data not shown).
1999). Hence, there is a discordance between the wide-
spread hematolymphoid expression of Ikaros and the Lymphoma and Homozygous Lethality Map
to a Point Mutation in Ikarosnarrower functional role as defined by protein-ablation
experiments. To map the chromosomal location of the Plstc mutation,
B6 Plstc animals were backcrossed to NOD.H2k (NODk)As a complementary strategy for genetic analysis of
the hematolymphoid system, we and others have ex- congenic mice. Typing of pooled DNA from 21 N2 ani-
mals that developed lymphoma against a panel of simpleplored the feasibility of using the chemical mutagen
ethylnitrosourea (ENU) to perform unbiased genome- sequence length polymorphism (SSLP) markers span-
ning the entire genome revealed linkage to D11Mit78wide mutagenesis screens in mice for dominant (Nolan
et al., 2000; Hrabe´ de Angelis et al., 2000) or recessive on proximal chromosome 11 (see Supplemental Data at
http://www.immunity.com/cgi/content/full/19/1/131/mutations (Kasarskis et al., 1998; Nelms and Goodnow,
2001; Herron et al., 2002). ENU induces single base DNA DC1). Additional backcross and intercross animals were
individually typed for recombination using markers be-substitutions so that mutant alleles frequently encode
proteins that are selectively inactivated in discrete func- tween D11Mit78 and D11Mit226, positioning the lym-
phoma susceptibility mutation within a 1.37 cM regiontional domains. Here, we describe a strikingly severe,
embryonically lethal mutation that establishes a role for between D11Mit106 and D11Mit2 (see Supplemental
Data).Ikaros in the development of a wide range of blood cells,
resulting from a point mutation that selectively inactivates When Plstc/ carriers were selected using the flank-
ing SSLPs and intercrossed, no homozygotes for theIkaros’ DNA binding. The contrast between this potent
Figure 1. Isolation of the Plastic Mouse Mutation
(A) Initial inheritance of T cell lymphoma (filled symbols) in pedigree from an ENU-mutagenized C57BL/6J (B6*) mouse.
(B) Incidence of T cell lymphoma in Plstc/ carriers and wild-type littermates. Data is from 226 B6 Plstc/ and 264 B6/NOD Plstc/ carriers,
and their / sibling controls.
(C) Representative CD3-TCR immunophenotype of thymic lymphoma in Plstc/ mice compared to normal thymocytes from a wild-type
control. The percentage of total lymphocytes is shown within gates.
(D) Schematic of large Ikaros isoform (Ikaros VI) showing missense histidine to arginine substitution at codon 191 in the DNA binding N-terminal
zinc finger 3 (F3). Shown below is the sequence from Ikaros exon 4 (E4) from Plstc/Plstc or wild-type fetal liver mRNA.
(E) Phenotype of E15.5 Plstc/Plstc embryo and wild-type sibling and corresponding cytospin preparations of circulating blood cells stained
with May-Gru¨nwald-Giemsa. Note the scarcity of fetal liver-derived anucleate erythrocytes (black arrows) in mutants, with those present often
small (black arrow) and sometimes nucleated (arrowhead). Yolk sac-derived primitive erythroid cells are also indicated (thick blue arrows).
(F) RNase protection analysis of -globin (left) and -globin (right) transcripts in E15.5 fetal liver. Human -actin was used as a loading control
for -globin. The migration of the undigested probes is shown in the left lanes and the protected RNA species on the right.
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preleukemic Plstc/ heterozygotes confirmed that theyTable 1. Genotyping of Progeny from Crosses of Heterozygous
Plstc/ Mice carried the mutation (data not shown). Moreover, typing
of informative recombinants by mutagenically separatedTotal Pups Live
PCR (MS-PCR) (Rust et al., 1993) for the H191R mutationAgea Typed (Litters) / Plstc/ Plstc/Plstc Plstc/Plstc
found no recombinants between H191R and the lym-
E12.5 22 (2) 7 11 4 4
phoma or anemia phenotypes (see Supplemental Data).E13.5 50 (5) 13 29 8 8
Consequently, we conclude that both phenotypes areE14.5 210 (19) 47 113 50 49
due to the IkarosPlstc (Plstc) mutation: in the heterozygousE15.5 433 (43) 100 227 106 92
E16.5 36 (4) 7 20 9 5 state mice are susceptible to T lymphoma, while homo-
E17.5 41 (4) 9 22 10 6 zygosity causes fatal embryonic anemia.
E18.5 19 (2) 2 12 5 1
E19.5 11 (1) 5 5 1 0
Defective Erythrocyte DifferentiationTotal 822 (80) 190 439 193 165
in Homozygous IkarosPlstc Mutants
Postnatal 678 (86) 237 441 0 0 May-Gru¨nwald-Giemsa staining of homozygous mutant
a The morning of vaginal plug discovery was taken as E0.5. fetal liver cells in cytospin and touch preparations and
electron microscopic analysis of liver sections revealed
normal cells corresponding to all stages of erythrocyte
differentiation, although the numbers of normoblastsPlstc genetic segment were born, and all died between
E15.5–E17.5 of fetal development (Table 1). Live E14.5– and nonnucleated reticulocytes were markedly reduced
(see Supplemental Data). RNase protection experimentsE15.5 homozygous fetuses were extremely pale and
anemic with a marked deficit of red cells in the vitelline indicated that there were no distinct differences in
-major and -globin transcript expression levels be-and umbilical circulations (Figure 1E), very low hemoglo-
bin and hematocrit in peripheral blood, and total red tween anemic Plstc/Plstc E15.5 fetal livers and their
nonanemic littermates (Figure 1F). This suggested thatblood cell numbers less than 20% of values in normal
littermates or heterozygotes (Table 2). The majority of there was no defect in the production of adult globins
nor any chain imbalance in globin in the mutants andred cells in peripheral blood were yolk sac derived and of
normal appearance, with fetal liver-derived erythrocytes that thalassemia could be excluded as a cause of the
fatal anemia. Nuclear extracts prepared from Plstc/Plstcless than 5% of controls (Figure 1E and Table 2). Fetal
liver cellularity of Plstc/Plstc E15.5 embryos was also fetal liver showed that there was normal EKLF DNA bind-
ing activity in gel shift assays with a specific EKLF su-found to be reduced to half that of wild-type littermates
(p 	 0.001) with Plstc/ embryos having moderately pershift (data not shown). Hematopoietic colony assays
in vitro revealed a small 40% reduction in the numberreduced numbers (p 
 0.02) (Figure 3A). The recessive
embryonically lethal anemia mapped to the same geno- of burst- (BFU-E) and colony-forming unit-erythroid
(CFU-E) precursors measured in Plstc/Plstc fetal liversmic region as the lymphoma susceptibility and the two
phenotypes did not segregate in over 2400 meioses compared to normal littermates (Table 2).
We applied flow cytometry-based phenotyping meth-genotyped (see Supplemental Data).
The Ikaros gene, located in this genomic interval, was ods to perform a quantitative analysis of cells at different
stages of erythroid differentiation in Plstc/Plstc fetal liv-a candidate for the Plstc mutation since heterozygous
IkarosDN animals also develop T cell lymphomas. Rese- ers (Figure 2A). Erythroid lineage-committed cells were
identified as CD71CD34CD45, with the more differ-quencing of the Ikaros cDNA coding region prepared by
reverse transcriptase PCR (RT-PCR) from Plstc/Plstc entiated stages distinguished by increasing TER-119
expression and decreasing DNA content as assayed byfetal liver RNA showed a single A→G transition at posi-
tion 572, resulting in a missense amino acid change Hoechst 33342 (H33342). The earliest erythroid-commit-
ted progenitor cells, megakaryocyte/erythrocyte-restrictedfrom histidine to arginine at codon 191 (H191R) (Figure
1D). This substitution disrupts the conserved Cys2His2 progenitors (MEPs) (Akashi et al., 2000a), were enumer-
ated as CD71c-kitCD34CD45TER-119 large cellsunit that normally tetrahedrally coordinates a zinc ion
between the antiparallel  sheet and  helix of the zinc (Figure 2A). There was no significant difference in MEP
numbers or in their immediate proerythroblast progenyfinger (Wolfe et al., 2000). The mutation would therefore
interfere with the tertiary structure of the N-terminal zinc with TER-119lo staining between Plstc/Plstc mutants and
nonanemic littermates. However, the numbers of cellsfinger 3 of Ikaros that is essential for DNA binding. Rese-
quencing of Ikaros cDNA prepared from thymic RNA of in the early to late erythroblast stages of differentiation
Table 2. Hematology of E15.5 Embryosa
Total RBC  106 Yolk Sac-Derived Fetal Liver-Derived BFU-E  104 CFU-E  104
Genotype Hb (g/l) Hct (%) per l RBC  106 per l RBC  106 per l per Fetal Liverb per Fetal Liverb
/ 85.6  6.0 32.3  2.8 5.8  1.5 0.4  0.04 5.4  1.4
5.0  0.4 17.7  1.8
Plstc/ 72.6  4.5 29.6  1.2 5.1  0.5 0.5  0.03 4.6  0.5
Plstc/Plstc 21.7  0.8 8.0  0.8 1.1  0.1 0.9  0.06 0.2  0.1 2.7  0.3 11.9  1.6
a Data shows mean SEM for three /, eight Plstc/, and five Plstc/Plstc embryos from two separate experiments.
b Results derived from two / and two Plstc/ embryos have been combined and compared with those from five Plstc/Plstc embryos.
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were decreased 80% in Plstc/Plstc mutants relative to Premature Extinction of c-kit upon Erythroid Lineage
Commitment in Homozygous IkarosPlstc Mutantswild-type littermates (p 	 0.001), and mature anucleate
Normally, c-kit is highly expressed on common myeloiderythrocytes were reduced to 10% of controls (p 	
progenitors (CMPs), GMPs, and MEPs (Akashi et al.,0.001). Hypoplasia was accompanied by increased num-
2000a), moderately expressed on TER-119lo proerythro-bers of small, dead cells in Plstc/Plstc fetal livers (data
blasts, and fully extinguished on mature TER-119hi eryth-not shown). These cells were TER-119, but many ex-
roblasts (Broudy, 1997). By contrast, in Plstc/Plstc fetalpressed CD71hi consistent with an erythroid lineage ori-
livers c-kit was expressed normally on CMPs and GMPs,gin. The anemia was therefore not due to deficits of
but on the MEPs c-kit was reduced to one-quarter ofstem cells previously shown in Ikaros targeted mutant
the levels seen in nonanemic littermates (p 
 0.006) andmice (Nichogiannopoulou et al., 1999); instead, the chief
little c-kit remained on proerythroblasts (Figure 2C anddefect in Plstc/Plstc mutants was a failure of normal
data not shown). This trait was recessive, with normalerythroblast growth and differentiation.
c-kit expression on heterozygotes. The normal expres-An in vitro coculture system was used to determine
sion of c-kit on myeloerythroid progenitors and subse-whether hypoplasia was autonomous to Plstc/Plstc ery-
quent premature extinction upon erythroid commitmentthroid cells and not secondary to abnormalities in an-
contrasts with the diminished expression reported pre-other cell type. Fetal liver cell suspensions from homozy-
viously on bone marrow hematopoietic stem cells ofgous mutants and sibling controls were labeled with the
mice lacking full-length Ikaros (Nichogiannopoulou etcell division tracking dye carboxyfluorescein diacetate
al., 1999).succinimidyl ester (CFSE) and cultivated in serum-free
medium supplemented with erythropoietin (Epo) and
Homozygous Mutant Fetal Liver Cells Failstem cell factor (SCF) (von Lindern et al., 2001). Erythroid
to Engraft Hematopoiesiscell divisions were then measured flow cytometrically
To further analyze the hematopoietic defects and ex-by progressive dilution of CFSE from TER-119 cells.
plore the later stages of lymphoid differentiation, weCompared to control cultures without added growth fac-
attempted to reconstitute the hematopoietic system oftors, both wild-type and Plstc/Plstc TER-119 cells had
lethally irradiated mice by transplanting Plstc/Plstc do-divided one to two times on day 2 of culture with Epo/
nor E15.5 fetal liver cells. Donor-derived cells bearingSCF (data not shown), but by day 3 a large fraction of
the Ly5a (CD45.1, also known as protein-tyrosine phos-wild-type erythroid cells had divided three or more times
phatase receptor-type C, PTPRca) allelic marker werewhereas a much smaller fraction of Plstc/Plstc cells di-
identified by flow cytometric staining in Ly5b (CD45.2)
vided multiple times (Figure 2B). When equal amounts
recipients. When wild-type Ly5a fetal liver cells were
of wild-type and Plstc/Plstc cells were cocultured, the
used as donors, the vast majority of Mac-1 cells in the
Plstc/Plstc erythroid defect was found to be cell autono-
recipient bone marrow were donor derived (see Supple-
mous as CFSE-labeled fetal liver cells displayed prolifer- mental Data). In marked contrast, Ly5a Plstc/Plstc donor
ation defects comparable to those seen in the separately cells failed to reconstitute the macrophage lineage (p 	
cultured mutant erythroid cells. The presence of wild- 0.001), a remarkable finding in light of the pronounced
type fetal liver failed to correct the proliferation of CFSE- expansion of GMP progenitors and Mac-1 cells in
labeled mutant cells, and, equally, the presence of mu- Plstc/Plstc fetal liver. Similar failure of reconstitution of
tant cells did not diminish the proliferation of CFSE- Mac-1 cells by Ly5a Plstc/Plstc donor cells was also
labeled wild-type cells in cocultures (Figure 2B). found in the blood of chimeras at 4 and 8 weeks after
fetal liver cell transplant (p 	 0.001). Equally, there was
no measurable reconstitution by Ly5a mutant cells of
Dysregulation of Myeloid Differentiation any other Mac-1 subsets in the marrow (p 	 0.001)
in Homozygous IkarosPlstc Mutants and blood (p 	 0.001) (see Supplemental Data), nor in
In contrast to the erythroid hypoplasia, Plstc/Plstc homo- specific myeloid and lymphoid cell subsets: Gr-1lo,
zygotes contained a large expansion of myeloid cells in Gr-1hi, and B220 in the bone marrow, blood, and spleen,
the fetal liver at E15.5 (Figure 2A). This was due to a 330% and Thy1 in the thymus (data not shown). This failure
increase in the numbers of granulocyte/macrophage- of mutant fetal liver cells to engraft hematopoiesis was
restricted progenitors (GMPs; CD34CD45FcR) (Akashi also observed in mixed 50%:50% wild-type:mutant co-
et al., 2000a) in the earliest stages of the myeloid lineage transplanted chimeras (see Supplemental Data). More-
(p	 0.001) and a comparable expansion in more mature over, no donor-derived leukocytes from mutant fetal
and granular Mac-1hi (390%; p	 0.001) and Gr-1lo (210%; liver could be detected in the spleen of irradiated recipi-
p 	 0.001) cells (Figure 2A). Unlike the recessive inheri- ents in short-term (14 day) engraftment assays (data not
tance of lethal anemia, an intermediate level of myeloid shown). Since the GMP subset is increased in the mutant
hyperplasia occurred in Plstc/ fetal liver, indicating fetal liver, these results suggest the IkarosPlstc mutation
semidominant inheritance of this trait in embryos. Termi- may cause a severe defect in the homing of these cells
nal granulocyte differentiation was nevertheless defec- to hematopoietic niches in adult recipients.
tive in Plstc/Plstc fetal livers as there were no detectable
Gr-1hi cells compared with controls (p 	 0.001) (Figure Defective Lymphocyte Development in Homozygous
2A). Like the failure of erythrocyte differentiation, the and Heterozygous IkarosPlstc Mutants
terminal granulocyte differentiation defect was purely Thymi from E15.5 wild-type fetuses are primarily com-
recessive, with normal numbers of Gr-1hi cells in hetero- prised of Thy1 T cell precursors, including a subset of
CD48 double-positive (DP) cells (Figure 3B) that havezygous fetal livers.
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Figure 2. Defective Erythroid and Myeloid Differentiation in Plstc/Plstc Fetal Liver
(A) Stages of erythroid (top) and myeloid (bottom) differentiation enumerated according to the flow cytometric markers shown. Erythroid panel:
CD71 is expressed and CD34 and CD45 are simultaneously lost at the earliest stages of commitment to the erythroid lineage on megakaryocyte/
erythrocyte progenitors (MEPs) prior to any TER-119 expression. Successive developmental stages are resolved and quantified by changes
in TER-119 and DNA content (H33342); these stages were sorted and verified by characteristic morphology in cytospin preparations stained
with May-Gru¨nwald-Giemsa (panels above). The mean total number of cells is shown with standard error of the mean (SEM) at each differentiation
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differentiated beyond the TCR- gene rearrangement mutant Ikaros alleles, in particular the IkarosDN allele,
their effects on the DNA binding activity of Ikaros werecheckpoint. By contrast, Plstc/ heterozygous embryos
lacked DP cells and the number of thymocytes and dou- determined using a gel shift assay following overexpres-
sion in 293T cells (Figure 4A). HA-tagged full-lengthble-negative (DN) Thy1precursors was reduced to 50%
of wild-type values (Figures 3B and 3C). The heterozy- Ikaros VI isoform (HA-VI) binds as a dimer to a consensus
Ikaros recognition sequence (Figure 4A, lane 2) (Cobbgous block in T cell differentiation was incomplete, how-
ever, as normal subsets of thymocytes and mature et al., 2000; Trinh et al., 2001). The internally deleted
short Ikaros I isoform (Flag-I) cannot bind DNA aloneT cells were present in Plstc/ animals at 4 weeks post-
natal (data not shown), with significantly increased num- (Trinh et al., 2001). However, when HA-VI and Flag-I are
coexpressed, a slower mobility band corresponding tobers of total Thy1 cells in the spleen (145%; p 
 0.05)
consistent with a preleukemic stage (Figure 3C). Plstc/ a multimer (Trinh et al., 2001) increased in intensity (Fig-
ure 4A, lanes 3–5). Supershift experiments confirmedPlstc homozygous fetuses lacked Thy1 cells entirely
(p 	 0.001) (Figures 3B and 3C), and the overall thymic that this complex contains both HA-VI and Flag-I,
whereas the dimeric complex contains only HA-VI (Fig-cellularity was 10% of wild-type (p 	 0.001) (Figure 3A).
Surprisingly, the remaining cells in Plstc/Plstc fetal thymi ure 4B, lanes 9–12). Thus, Flag-I overexpression did
not inhibit DNA binding by Ikaros VI dimers but ratherwere B220CD19 cells (Figure 3B), suggesting that
lymphocyte differentiation abortively forms B cell pre- associated with these dimers to form multimers. By con-
trast, when full-length IkarosPlstc protein (Flag-191R) wascursors instead of T lineage cells.
In conjunction with the failure of T lymphopoiesis, coexpressed with HA-VI, the dimeric complex was
greatly diminished (Figure 4A, lanes 6–8). A similar resultB lymphocyte differentiation was absent in Plstc/Plstc
homozygotes and partially blocked in heterozygotes. was obtained on analysis of another point mutation in
Ikaros zinc finger 2, Flag-159A, which also abolishesIn liver of wild-type E15.5 fetuses, both B220CD19
uncommitted progenitors and B220CD19 B lineage- DNA binding but leaves the finger structure intact (data
not shown). Since the concentrations of Flag-191R andcommitted progenitors were clearly apparent as distinct
populations (Figure 3B). Homozygous Plstc/Plstc fetal Flag-I were comparable (Figure 4A, lower panel), these
results demonstrate that Ikaros proteins containing sin-liver lacked committed B220CD19 pro-B cells (p 	
0.001) (Figures 3B and 3C) but paradoxically contained gle amino acid substitutions in the DNA binding domain
form DNA binding-incompetent dimers with Ikaros VIincreased numbers of B220CD19 cells (240%; p 	
0.001). The latter expressed CD43 consistent with an more efficiently than do the short isoforms lacking this
domain. Since both mutant classes contain the dimer-early B lineage precursor (Hardy et al., 2000) but did not
express NK cell markers NK1.1 (Rolink et al., 1996) or ization domain, these results provide strong evidence
for the existence of a second domain that stablizes iso-DX5 (Tudor et al., 2000). B cell differentiation also failed
to progress beyond the B220CD19 stage in heterozy- form VI dimers. This putative dimer stabilization domain
(DSD) is absent in isoform I, making this form relativelygous Plstc/ fetal liver (Figure 3B), but this block was
incomplete because B220CD19 cells were present in ineffective in competing with full-length species for di-
mer formation. The DSD is distinct from the multimeriza-normal numbers in bone marrow of 4-week-old hetero-
zygotes (Figure 3C). Nevertheless, differentiation past tion domain because isoform I forms multimers with
isoform VI dimers quite readily.the IgH-gene rearrangement checkpoint was diminished
in Plstc/ bone marrow, based upon a significant accu- Comparable differences between the two mutant
classes were seen in their subcellular localization tomulation of B220loCD43 pro-B cells (180%; p 
 0.04)
and a corresponding decrease in B220loCD43 pre-B pericentromeric heterochromatin, which requires DNA
binding and has been implicated in heritable silencingcells (20%; p 	 0.001) and B220hiCD43 (50%; p 	 0.01)
subsets. B lymphocytes that overcame this partial devel- of Ikaros target genes (Brown et al., 1997, 1999; Cobb
et al., 2000; Smale and Fisher, 2002). Previous studiesopmental block established normal mature B cell com-
partments, expressing wild-type levels of IgM, IgD, showed that in NIH 3T3 cells, Ikaros I cannot disrupt
the pericentromeric localization of Ikaros VI but ratherCD21, and CD23 (data not shown).
migrates to the pericentromeric foci in association with
Ikaros VI (Trinh et al., 2001). Like Ikaros I, Flag-191RLoss of DNA Binding by IkarosPlstc Protein
but Normal Dimerization failed to localize to pericentromeric foci when expressed
in 3T3 cells alone (Figure 4Ce and 4Cf). However, whenTo elucidate the biochemical reasons for the more se-
vere and widespread hematopoietic defects resulting coexpressed with wild-type HA-VI, Flag-191R remained
diffuse and disrupted the pericentromeric localizationfrom the IkarosPlstc point mutation compared to the other
stage per fetal liver. Myeloid panel: Granulocyte/macrophage progenitors (GMPs) are c-kitCD34CD45FcRMac-1Gr-1CD71TER-119.
More differentiated macrophages and granulocytes were enumerated as c-kitFcRMac-1hi, Gr-1lo, and Gr-1hi. All data are from more than
ten Plstc/Plstc fetuses and their sibling controls.
(B) Fetal liver cells from mutant embryos and wild-type controls were labeled with CFSE and cultured with Epo and SCF. The fraction of
CFSE-labeled erythroid cells that divided multiple times is shown, as tracked by progressive dilution of CFSE dye from labeled TER-119
cells. The small apparent increase in mutant cell proliferation in cocultures is due to slight overlap of the large population of unlabeled wild-
type cells into CFSElo mutant cell gate. Data is from six Plstc/Plstc mutant fetuses and six wild-type sibling controls, and is representative of
two separate experiments.
(C) Cell surface expression of c-kit (mean SEM) on GMPs and MEPs. All data are from more than ten Plstc/Plstc fetuses and their sibling
controls.
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Figure 3. Defects in T and B Cell Differentiation in Plstc Mutants
(A) Total cellularity (mean SEM) of thymus and liver from E15.5 embryos. Thymus and liver data is from 18 and 29 wild-type /, 24 and
75 Plstc/, and 12 and 56 Plstc/Plstc embryos, respectively.
(B) T and B cell differentiation in E15.5 wild-type, Plstc/, and Plstc/Plstc embryos and in the bone marrow of young mice at 4 weeks of age.
Percentages of total cells analyzed are shown within gates.
(C) Numbers of T and B cell subsets (mean SEM) of more than six Plstc/Plstc embryos, nine Plstc/ mice, and their sibling controls.
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Figure 4. DNA Binding and Subnuclear Localization of Mutant Ikaros Proteins
(A) Gel shift experiments (top) and Western blots (middle and bottom) were performed with nuclear extracts from 293T cells containing empty
vector (lane 1) or with expression vectors for HA-tagged full-length Ikaros VI alone (lane 2) or with increasing amounts of either Flag-I (lanes
3–5) or Flag-191R (lanes 6–8). The bands corresponding to the dimeric and multimeric gel shift complexes are indicated (top panel), as are
the Western blot bands corresponding to HA-VI (middle), Flag-I, and Flag-191R (bottom).
(B) Antibody supershifts were performed with 293T extracts containing no Ikaros (lanes 1–4), HA-VI (lanes 5–8), HA-VI  Flag-I (lanes 9–12),
or HA-VI  Flag-191R (lanes 13–16).
(C) Confocal microscopy was performed with NIH 3T3 cells infected with retroviruses expressing HA-Ikaros VI and Flag-191R. The cells were
stained with antibodies to HA (FITC-green) and Flag (Texas Red). In (a)–(c) are two cells expressing only HA-VI, in (d)–(f) is a cell only expressing
Flag-191R, and in panels (g)–(i) is a cell expressing both HA-VI and Flag-191R.
(D) Ikaros localization (yellow and green) by confocal immunofluorescence is shown in cells from two anemic Plstc/Plstc fetal livers and one
nonanemic wild-type sibling control. DNA is stained with propidium iodide (red). Results are representative of seven Plstc/Plstc and four wild-
type livers analyzed.
of the wild-type protein (Figure 4Cg–4Ci). The same ef- made. In 3T3 cells, targeting of Aiolos to pericentromeric
foci was disrupted by coexpression of the mutant Ikarosfect was observed with the more subtle mutation in
finger 2 (Flag-159A) (data not shown). Consistent with Flag-191R (Figure 5Ag–5Ai). By contrast, short Ikaros I
isoform (Ikaros NLS I) (Trinh et al., 2001) did not disruptthese results, Ikaros was primarily in large foci which
is characteristic of pericentromeric heterochromatin in its localization but instead migrated to the centromeric
foci in association with Aiolos (Figure 5Aj–5Al). Thus,wild-type fetal liver cells (Figure 4D). In contrast, Ikaros
was expressed at normal levels but did not localize to the Ikaros point mutant protein competes efficiently with
Aiolos.these foci in the Plstc/Plstc embryos (Figure 4D).
IkarosPlstc Protein Efficiently Pairs and Interferes Anemia Is Due to Loss of Ikaros Function
The fact that lethal anemia occurs in IkarosPlstc homozy-with Ikaros Family Members
The more severe hematopoietic phenotypes in IkarosPlstc gotes but not in Ikarosnull animals could theoretically be
explained by toxic neomorphic or dominant-negativemutants compared to Ikarosnull or IkarosDN mice cannot
be explained by the loss of DNA binding or pericentro- effects of the point mutant protein that require a thresh-
old amount only achieved when two copies of the mutantmeric targeting since all three mutations eliminate these
functions. However, other Ikaros family members are allele are present. In addition, it remained formally possi-
ble that a separate mutation in another tightly linkedalso expressed in hematopoietic cells. Because these
proteins, such as Aiolos (Morgan et al., 1997), bind the gene might account for the more widespread failure of
hematolymphoid differentiation. To test these alterna-same DNA sequences and share the dimerization do-
mains to form homo- and heterodimers, they may par- tives, we crossed IkarosPlstc heterozygotes with animals
carrying the Ikarosnull allele and analyzed the erythroidtially substitute when no full-length Ikaros protein is
Immunity
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Figure 5. Effect of the Plstc Mutation on Ikaros and Ikaros Family Member Proteins
(A) Subnuclear localization of Aiolos (FITC, green) was examined in NIH 3T3 cells in the absence and presence of the Plstc mutant protein
(Flag-191R, Texas Red) or short Ikaros I (Ikaros NLS I, Texas Red).
(B) Erythropoietic failure in fetal liver and blood (mean SEM) of compound heterozygous animals at E15.5 resulting from a cross between
IkarosPlstc/ and Ikarosnull/ parents.
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phenotype of compound heterozygotes at E15.5 com- Ikaros may directly or indirectly regulate these or other
factors to activate or repress erythroid-specific genespared to littermate controls. As expected, there was no
significant reduction in fetal liver erythroid cells or in during later erythropoietic stages. Alternatively, the de-
fect could be explained by the premature extinction offetal blood erythrocytes in animals that were singly het-
erozygous for the Ikarosnull or IkarosPlstc alleles (Figure c-kit on erythroid lineage cells (Figure 2C), which may
be a direct or indirect effect of the IkarosPlstc mutation.5B). By contrast, IkarosPlstc/null compound heterozygotes
were severely anemic, with values comparable to Ikar- Comparable hypoplasia and anemia occur in E15.5 W/
W mice homozygous for a c-kit loss of function mutationosPlstc/Plstc homozygotes. The fact that a single copy of
the IkarosPlstc allele caused erythroid failure when placed (Russell and McFarland, 1965) and when binding of SCF
to c-kit is blocked in utero by antibodies (Ogawa et al.,against the null allele confirms that this is indeed due
to loss of Ikaros function and not to toxic or dominant- 1993).
The erythropoietic deficiency in IkarosPlstc homozy-negative effects of a double dose of the IkarosPlstc allele.
gotes is paralleled by the failure to form Gr-1hi granulo-
cytes and contrasts with the greatly increased numbersDiscussion
of GMPs and differentiated Mac-1 progeny (Figure 2A).
A similar finding in relation to an expanded fetal myeloidThe data above demonstrate that Ikaros orchestrates a
much broader role in hematolymphoid differentiation cell compartment was made in recent studies involving
IkarosL/L mice (Dumortier et al., 2003). The more severethan previously known, extending well beyond the es-
tablished function in lymphoid differentiation. Homozy- granulocyte deficiency associated with the Plstc allele
contrasts with normal numbers of Gr-1hi fetal liver cellsgous Plastic mutants have normal numbers of commit-
ted fetal liver erythroid progenitors, but these fail to in Ikarosnull mice (Wang et al., 1996). However, reduced
numbers of Gr-1hi cells and increased numbers ofproduce significant numbers of progeny in the terminal
stages of erythroid differentiation (Figure 2A). Several Mac-1 cells were noted selectively in bone marrow but
not spleen or peripheral tissues of postnatal Ikarosnull,mechanisms could contribute to this hypoplasia. A gen-
eral defect in chromatin compaction prior to nuclear IkarosDN, and Ikaros L homozygotes, although interpreta-
tion was clouded by the possible effects of opportunisticextrusion in late erythrocyte differentiation is a formal
possibility since Ikaros has been shown to interact with infections. No role for Ikaros in myeloid differentiation
is currently recognized (Friedman, 2002). The effects ofchromatin remodeling complexes in both lymphocytes
(Kim et al., 1999) and erythroid cells (O’Neill et al., 2000). the Plstc point mutant allele on erythroid, myeloid, and
granulocyte differentiation makes it reasonable to hy-However, this hypothesis is not consistent with the de-
creased numbers of earlier precompaction stage eryth- pothesize that Ikaros acts directly or indirectly to alter
the balance among the emerging networks of crossan-roblasts (Figure 2A) nor with the presence of condensed
chromatin in the late normoblasts that are present (see tagonistic transcription factors that establish differentia-
tion of these cell types from a common progenitor (Can-Supplemental Data at http://www.immunity.com/cgi/
content/full/19/1/131/DC1). Thalassemia due to defec- tor and Orkin, 2001). The IkarosPlstc strain provides a
useful tool for future studies to explore this interplay.tive adult globin production or chain imbalance can also
be excluded based on normal expression as assayed The failure to achieve short- or long-term reconstitu-
tion of hematopoiesis in irradiated recipients of IkarosPlstcby RNase protection experiments (Figure 1F). This result
contrasts with data suggesting that Ikarosnull mice have fetal liver cells (see Supplemental Data) is surprising
given the increased numbers of GMPs in the inoculumincreased embryonic globin RNA expression and de-
layed embryonic to adult -major globin switching (Lo- which would normally have short-term reconstituting
activity (Akashi et al., 2000a). A comparable failure ofpez et al., 2002), although it is consistent with the normal
expression of adult globins measured by gene chip anal- reconstitution has previously been shown in homozy-
gous IkarosDN bone marrow cells, while Ikarosnull mutantsysis in the same study. Embryonic globin gene expres-
sion was not examined in IkarosPlstc homozygotes as the had milder repopulating defects (Nichogiannopoulou et
al., 1999). These results raise the possibility that Ikarosyolk sac stages of erythropoiesis appear normal (Figure
1E). An increase in the ratio of embryonic to adult globin is required for correct stem cell migration/colonization
of adult hematopoietic niches.would be expected, however, as a secondary effect of
the deficiency of fetal liver erythrocytes and normal The failure of T and B cell differentiation in homozy-
gous and heterozygous Plstc fetuses parallels defectsnumbers of yolk sac erythrocytes (Table 2). Normal glo-
bin expression in IkarosPlstc homozygotes argues against previously described in Ikarosnull, IkarosDN, and Ikaros L
homozygotes. The IkarosPlstc allele is more potent, how-a general defect in the expression of erythroid-specific
zinc finger transcription factors such as GATA-1 (Pevny ever, because a single copy causes these lesions (Figure
3B) that are almost as severe as homozygosity for theet al., 1991), FOG-1 (Tsang et al., 1997), or EKLF (Nuez
et al., 1995; Perkins et al., 1995). While EKLF was found Ikarosnull allele. The paradoxical presence of B220
CD19 cells in fetal thymi of homozygous IkarosPlstc em-to bind normally to DNA in the homozygous embryos,
(C) Proposed mechanism for the more complete loss of Ikaros function in mutants with IkarosPlstc allele. Dimers, multimers, and other chromatin-
modifying proteins normally assemble containing full-length Ikaros (dark red) and related family members (light green). When the full-length
Ikaros isoform is absent (Ikarosnull) or internally truncated (IkarosDN), other family members become free to assemble comparable complexes
and partially substitute for functions normally performed by Ikaros. By contrast, the IkarosPlstc protein is null for DNA binding but retains its
normal capacity to assemble into protein complexes, blocking compensatory assembly and substitution by related proteins.
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Flow Cytometry Analysisbryos despite the complete absence of Thy-1 cells may
A full list of flow cytometry reagents used in this study is availablesuggest a role for Ikaros in the lineage decision between
in the Supplemental Data at http://www.immunity.com/cgi/content/T and B lymphocytes. B cells differentiate at low fre-
full/19/1/131/DC1.
quency in normal thymus (Akashi et al., 2000b) and the
shift in T-B thymic precursor cell ratio of IkarosPlstc homo- In Vitro Fetal Liver Cell Culture
zygotes resembles the effects of conditional Notch1 de- Labeling of fetal liver cells with CFSE (Molecular Probes, Eugene,
OR) was at 37C for 10 min at a final concentration of 5 M in PBSficiency (Radtke et al., 1999).
containing 0.1% BSA, followed by quenching using 5 volumes ofThe Plastic mutation illustrates an unrecognized class
cold PBS containing 10% fetal bovine serum. Cells were plated atof genetic allele that appears to have broad importance
2  106/ml in StemPro-34 (Invitrogen/Life Technologies, Carlsbad,
for elucidating gene functions in mammals. The fact that CA) with 2 U/ml human recombinant Epo (gift from M. Cook) and
homozygosity for the IkarosPlstc allele yields much more 50 ng/ml murine recombinant SCF (gift from D. Hilton and J. Zhang).
severe hematopoietic defects than IkarosDN, which in
turn is more severe than Ikarosnull, would classically be Hematological Analysis
For collecting blood for cytospins, embryos with attached placentasinterpreted as indicating that the point mutant protein
were washed free of maternal blood, and the cord was cut withouthas acquired new (neomorphic) or interfering (antimor-
damaging the embryos. Blood was collected by placing embryos inphic/dominant-negative) activities that do not reflect
PBS (100 l) on ice. For complete counts, whole blood pipetted from
normal functions of Ikaros. The recessive behavior the severed neck of embryos was diluted 1:20 in acid citrate dextrose
would in this case need to be explained by requiring a and analyzed by cell counter (Beckman Coulter, Fullerton, CA).
threshold amount of the mutant protein achieved only
In Vitro Colony-Forming Assayswhen two mutant copies are present. This interpretation
Single-cell fetal liver suspensions were plated in 1.5 ml methylcellu-is ruled out by the equally severe hematopoietic defect
lose medium with 4 U/ml Epo and 250 ng/ml SCF. After 7 (BFU-E)in animals with a single copy of the IkarosPlstc allele in
and 2 (CFU-E) days of incubation, colonies of typical BFU-E and
combination with a null allele on the other chromosome CFU-E morphology were counted. Erythroid identity was confirmed
(Figure 5B). The compound heterozygote firmly estab- by May-Gru¨nwald-Giemsa staining of cytospins from single col-
lishes that erythroid failure reflects loss of Ikaros func- onies.
tion itself in a way that fails to be revealed when the
Adoptive Transfer of Fetal Liver Cellsfull-length Ikaros protein is removed from the cell milieu.
This was performed as described previously (Miosge et al., 2002)When part or all of the Ikaros protein is eliminated by
except that recipients were (C57BL/6J x B10.H-2k.BR)F1 mice andnull or deletion mutations, this creates a void in larger
5  105 (14 day CFU-S colony assays) or 2  106 (4 and 8 week
macromolecular complexes normally containing Ikaros reconstitution assays) cells from donor embryos in 300 l RPMI
that can potentially be filled by Ikaros-related proteins 1640 medium (Invitrogen/Life Technologies) were transplanted per
(Morgan et al., 1997; Hahm et al., 1998; Kelley et al., mouse.
1998; Honma et al., 1999; Perdomo et al., 2000). By
Genetic Mappingcontrast, the IkarosPlstc point mutation selectively inacti-
Tail genomic DNA was extracted from (NODk x B6Plstc/) x NODkvates DNA binding but preserves specific assembly/
N2 mice using QIAamp DNA Mini Kit (Qiagen, Hilden, Germany).scaffold functions of the long Ikaros isoform so that it
Equimolar DNA aliquots were pooled from mutants and scanned
continues to fill its normal niches in the cell. This reces- with a simple sequence length polymorphism (SSLP) mapping panel
sive niche-filling allele thus inactivates Ikaros’ normal spanning the mouse genome. The panel was established for 107
functions without creating the opportunity for compen- polymorphic markers between B6 and NOD with a genome-wide
spacing of less than 20 cM (marker list available on request). Markerssatory substitution by related proteins (Figure 5C). Inter-
were derived from the Whitehead/MIT website (http://www-genome.estingly, this particularly informative class of mutant
wi.mit.edu/).allele has not been recognized in invertebrate mutagen-
esis, with a single elegant exception in the case of op-
RNA and DNA Analyses
portunistic compensation between yeast MAP kinase RNA isolated from mouse tissues using TRIzol Reagent (Invitrogen/
homologs (Madhani et al., 1997). Since differential as- Life Technologies) was transcribed to cDNA using Superscript pre-
sembly into multimolecular complexes imparts specific- amplification system (Invitrogen/Life Technologies) with oligo(dT)
primer. For amplification of Ikaros cDNA (exons 1–7), primers wereity for many cellular proteins, our results demonstrate
designed to amplify overlapping fragments (sequences available ona type of mammalian mutation to overcome the problem
request) and products were purified with QIAquick Gel Extractionof opportunistic substitution by gene family members in
Kit (Qiagen). Automated sequencing was performed on an ABI 377
mammalian genetic analysis. The Plastic mutant mouse sequencer (Applied Biosystems, Foster City, CA). Primers used to
strain described here with its expanded constellation of screen for the H191R mutation by MS-PCR (Rust et al., 1993) were
developmental defects will be a useful tool for research- 5-GTGAACGGCCTTTCCAGTGC-3 (sense), 5-GTGAACATACCG
GAGTGCGTCCTCAAGT-3 (antisense-wild-type), and 5-ATGGCers to explore the molecular basis of hematolymphoid
ATCCCTGCCATGCTCATGGAACATACCGGAGTGCGTCCTCGGGC-3cell differentiation and leukemia.
(antisense mutant). RNase protection analysis of globin transcripts
in fetal liver RNA were conducted as previously described (PerkinsExperimental Procedures
et al., 1995).
Mice
Biochemical and Confocal AnalysesWe obtained C57BL/6J mice (Jackson Laboratory) for mutagenesis,
Retroviral expression plasmids for HA- or Flag-tagged Ikaros pro-NOD.H2k congenics (L. Wicker) for mapping studies, and Ikarosnull/
teins were described previously (Cobb et al., 2000; Trinh et al., 2001)mice (K. Georgopoulos) for compound heterozygous studies. Plstc
or prepared by two-step PCR sewing (Trinh et al., 2001). Nuclearpedigree was established from the G1 heterozygote identified within
extracts were prepared from fetal liver or transiently transfecteda large-scale ENU mutagenesis screen (Nelms and Goodnow, 2001).
293T cells (Cobb et al., 2000). DNA binding activities of EKLF fromThe G1 founder was bred from a G0 mutagenized male injected intra-
peritoneally with ENU (Sigma, St Louis, MO) at 10 weeks of age. fetal liver cells were assayed by gel shift as previously described
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(Perkins et al., 1995). DNA binding activities of overexpressed pro- Herron, B.J., Lu, W., Rao, C., Liu, S., Peters, H., Bronson, R.T.,
Justice, M.J., McDonald, J.D., and Beier, D.R. (2002). Efficient gener-teins were examined by gel shift using an oligonucleotide probe
containing consensus Ikaros binding site  sat A (Cobb et al., 2000). ation and mapping of recessive developmental mutations using ENU
mutagenesis. Nat. Genet. 30, 185–189.NIH 3T3 cells infected with recombinant retroviruses were analyzed
by confocal microscopy (Cobb et al., 2000; Trinh et al., 2001) using Honma, Y., Kiyosawa, H., Mori, T., Oguri, A., Nikaido, T., Kanazawa,
antibodies listed in the Supplemental Data. K., Tojo, M., Takeda, J., Tanno, Y., Yokoya, S., et al. (1999). Eos: a
novel member of the Ikaros gene family expressed predominantly
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